Department of Nucleic Acids Bioengineering, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland.
Molecules. 2022 Sep 3;27(17):5682. doi: 10.3390/molecules27175682.
Oligonucleotide tools, as modulators of alternative splicing, have been extensively studied, giving a rise to new therapeutic approaches. In this article, we report detailed research on the optimization of bifunctional antisense oligonucleotides (BASOs), which are targeted towards interactions with hnRNP A1 protein. We performed a binding screening assay, Kd determination, and UV melting experiments to select sequences that can be used as a high potency binding platform for hnRNP A1. Newly designed BASOs were applied to regulate the mutually exclusive alternative splicing of the gene. Our studies demonstrate that at least three repetitions of regulatory sequence are necessary to increase expression of the PKM1 isoform. On the other hand, PKM2 expression can be inhibited by a lower number of regulatory sequences. Importantly, a novel branched type of BASOs was developed, which significantly increased the efficiency of splicing modulation. Herein, we provide new insights into BASOs design and show, for the first time, the possibility to regulate mutually exclusive alternative splicing BASOs.
寡核苷酸工具作为可变剪接的调节剂,已经得到了广泛的研究,为新的治疗方法提供了依据。在本文中,我们报告了针对 hnRNP A1 蛋白相互作用的双功能反义寡核苷酸(BASO)的优化的详细研究。我们进行了结合筛选分析、Kd 确定和 UV 融解实验,以选择可作为 hnRNP A1 的高效力结合平台的序列。新设计的 BASO 被用于调节 基因的相互排斥的可变剪接。我们的研究表明,至少需要三个重复的调节序列才能增加 PKM1 同工型的表达。另一方面,PKM2 的表达可以通过较少数量的调节序列来抑制。重要的是,开发了一种新型的分支型 BASO,其显著提高了剪接调节的效率。在此,我们提供了对 BASO 设计的新见解,并首次展示了调节相互排斥的可变剪接 BASO 的可能性。